This HTML5 document contains 10 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dctermshttp://purl.org/dc/terms/
marcrelhttp://id.loc.gov/vocabulary/relators/
n2https://hal.archives-ouvertes.fr/halshs-00680996#
n7http://www.idref.fr/155511157/
dchttp://purl.org/dc/elements/1.1/
n6http://www.idref.fr/067203779/
n11http://www.idref.fr/060772239/
n8http://www.idref.fr/113205252/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://www.idref.fr/091953642/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://www.idref.fr/074036572/
Subject Item
n2:id
marcrel:aut
n4:id n6:id n7:id n8:id n9:id n11:id
dcterms:bibliographicCitation
Sebban Catherine, Lefranc Anne, Perrier Lionel, Moreau Philippe, Espinouse Daniel, Schmidt A., Kammoun L., Ghesquières Hervé, Ferlay C., Bay Jacques-Olivier, Lissandre Séverine, Pérol David, Michallet M., Quittet Philippe. A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). European Journal of Cancer, Elsevier, 2012, 48 (5), pp. 713-720 Sebban Catherine, Lefranc Anne, Perrier Lionel, Moreau Philippe, Espinouse Daniel, Schmidt A., Kammoun L., Ghesquières Hervé, Ferlay C., Bay Jacques-Olivier, Lissandre Séverine, Pérol David, Michallet M., Quittet Philippe . A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study) . European Journal of Cancer, 2012, 48 (5), pp . 713-720
dcterms:title
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
dc:date
2012